Oxford Nanopore's announcement of its new whole-genome sequencing technology has set the genomics world talking once again about the $1,000 genome and how it could change research and healthcare. It "has the promise of taking the enterprise of sequencing an individual's genome out of the basic science laboratory, and out to the consumer mass market," says Razib Khan at The Crux blog.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.